The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
TNF-α and Obesity
Abstract
Obesity, an epidemic of our times with rates rising to alarming levels, is associated with comorbidities including cardiovascular diseases, arthritis, certain cancers, and degenerative diseases of the brain and other organs. Importantly, obesity is a leading cause of insulin resistance and type 2 diabetes. As emerging evidence has shown over the last decade, inflammation is one of the critical processes associated with the development of insulin resistance, diabetes and related diseases, and obesity is now considered as a state of chronic low-grade inflammation. Adipose tissue, apart from its classical role as an energy storage depot, is also a major endocrine organ secreting many factors, whose local and circulating levels are affected by the degree of adiposity. Obesity leads to infiltration of the expanded adipose tissue by macrophages and increased levels in proinflammatory cytokines. The first indication for increased cytokine release in obesity was provided by the identification of increased expression of TNF-alpha, a proinflammatory cytokine, in the adipose tissue of obese mice in the early 1990s. TNF-alpha is expressed in and secreted by adipose tissue, its levels correlating with the degree of adiposity and the associated insulin resistance. Targeting TNF-alpha and/or its receptors has been suggested as a promising treatment for insulin resistance and type 2 diabetes. This review will summarize the available knowledge on the role of TNF-alpha in obesity and related processes and the potential implications of the above in the development of new therapeutic approaches for obesity and insulin resistance. Recent data from clinical studies will also be described together with late findings on the pathogenesis of obesity and insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Adipokines: inflammation and the pleiotropic role of white adipose tissue
Trayhurn, P., & Wood, I. S. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041213 · Cited by 2,210
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
CCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335c1 · Cited by 1,425
Endoplasmic Reticulum Stress Plays a Central Role in Development of Leptin Resistance
Ozcan, L., Ergin, A. S., Lu, A., Chung, J., Sarkar, S., Nie, D., Myers, M. G., & Ozcan, U. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.004 · Cited by 875
Suganami, T., Tanimoto-Koyama, K., Nishida, J., Itoh, M., Yuan, X., Mizuarai, S., Kotani, H., Yamaoka, S., Miyake, K., Aoe, S., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251608.09329.9a · Cited by 812
Is obesity an inflammatory condition?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00672-4 · Cited by 799
Sarraf, P., Frederich, R. C., Turner, E. M., Ma, G., Jaskowiak, N. T., Rivet, D. J., Flier, J. S., Lowell, B. B., Fraker, D. L., & Alexander, H. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.1.171 · Cited by 791
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737
Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Moller, D. E. (2000) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(00)00272-1 · Cited by 718
The relation of body fat mass and distribution to markers of chronic inflammation
Festa, A., D'Agostino Jr, R., Williams, K., Karter, A., Mayer-Davis, E., Tracy, R., & Haffner, S. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801792 · Cited by 706
Adiponectin – a key adipokine in the metabolic syndrome
Whitehead, J. P., Richards, A. A., Hickman, I. J., Macdonald, G. A., & Prins, J. B. (2006) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00510.x · Cited by 644
Ruan, H., Hacohen, N., Golub, T. R., Van Parijs, L., & Lodish, H. F. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1319 · Cited by 529
Inflammation and the IKKβ/IκB/NF-κB axis in obesity- and diet-induced insulin resistance
Shoelson, S. E., Lee, J., & Yuan, M. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802501 · Cited by 474
Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes
Song, M. J., Kim, K. H., Yoon, J. M., & Kim, J. B. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.170 · Cited by 453
Emanuelli, B., Peraldi, P., Filloux, C., Chavey, C., Freidinger, K., Hilton, D. J., Hotamisligil, G. S., & Van Obberghen, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104602200 · Cited by 449
Adiponectin protects LPS-induced liver injury through modulation of TNF-α in KK-Ay obese mice
Masaki, T., Chiba, S., Tatsukawa, H., Yasuda, T., Noguchi, H., Seike, M., & Yoshimatsu, H. (2004) · Hepatology · doi:10.1002/hep.20282 · Cited by 402
Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
Mohamed-Ali, V., Goodrick, S., Bulmer, K., Holly, J. M. P., Yudkin, J. S., & Coppack, S. W. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e971 · Cited by 398
Hofmann, C. (1994) · Endocrinology · doi:10.1210/en.134.1.264 · Cited by 387
Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi, P., Xu, M., & Spiegelman, B. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119715 · Cited by 314
Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 Diabetes
Goldfine, A. B., Silver, R., Aldhahi, W., Cai, D., Tatro, E., Lee, J., & Shoelson, S. E. (2008) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00026.x · Cited by 294
Straczkowski, M., Dzienis-Straczkowska, S., Stêpieñ, A., Kowalska, I., Szelachowska, M., & Kinalska, I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020135 · Cited by 280
Ventre, J., Doebber, T., Wu, M., MacNaul, K., Stevens, K., Pasparakis, M., Kollias, G., & Moller, D. E. (1997) · Diabetes · doi:10.2337/diab.46.9.1526 · Cited by 275
Mantzoros, C. S., Moschos, S., Avramopoulos, I., Kaklamani, V., Liolios, A., Doulgerakis, D. E., Griveas, I., Katsilambros, N., & Flier, J. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4323 · Cited by 274
Role of macrophage tissue infiltration in metabolic diseases
Bouloumié, A., Curat, C. A., Sengenès, C., Lolmède, K., Miranville, A., & Busse, R. (2005) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/01.mco.0000172571.41149.52 · Cited by 262
Uysal, K. T., Wiesbrock, S. M., & Hotamisligil, G. S. (1998) · Endocrinology · doi:10.1210/endo.139.12.6337 · Cited by 247
Tracey, K. J., Morgello, S., Koplin, B., Fahey, T. J., Fox, J., Aledo, A., Manogue, K. R., & Cerami, A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114937 · Cited by 232
Paquot, N. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.1316 · Cited by 212
TNFα release by the nonfat cells of human adipose tissue
Fain, J. N., Bahouth, S. W., & Madan, A. K. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802594 · Cited by 203
Cerami, A., Ikeda, Y., Le Trang, N., Hotez, P. J., & Beutler, B. (1985) · Immunology Letters · doi:10.1016/0165-2478(85)90165-8 · Cited by 202
Xu, H., Uysal, K. T., Becherer, J. D., Arner, P., & Hotamisligil, G. S. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1876 · Cited by 189
Cheung, A., Ree, D., Kolls, J. K., Fuselier, J. A., Coy, D. H., & Bryer‐Ash, M. (1998) · Endocrinology · doi:10.1210/endo.139.12.6336 · Cited by 184
TNF-α-Induced Insulin Resistance In Vivo and Its Prevention by Troglitazone
Miles, P. D. G., Romeo, O. M., Higo, K., Cohen, A., Rafaat, K., & Olefsky, J. M. (1997) · Diabetes · doi:10.2337/diab.46.11.1678 · Cited by 183
Obesity and diabetes in TNF-alpha receptor- deficient mice.
Schreyer, S. A., Chua, S. C., & LeBoeuf, R. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2849 · Cited by 172
Wang, B., & Trayhurn, P. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0055-8 · Cited by 163
Serum concentrations of TNF-α and soluble TNF-α receptors in obesity
Zahorska‐Markiewicz, B., Janowska, J., Olszanecka‐Glinianowicz, M., & Żurakowski, A. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801398 · Cited by 151
Kirk, E. A., Sagawa, Z. K., McDonald, T. O., O'Brien, K. D., & Heinecke, J. W. (2008) · Diabetes · doi:10.2337/db07-1061 · Cited by 149
Hube, F., & Hauner, H. (1999) · Hormone and Metabolic Research · doi:10.1055/s-2007-978810 · Cited by 142
Yazdani‐Biuki, B., Stelzl, H., Brezinschek, H. P., Hermann, J., Mueller, T., Krippl, P., Graninger, W. B., & Wascher, T. C. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01390.x · Cited by 133
Plasma concentrations of soluble TNF-alpha receptors in obese subjects
Hauner, H., Bender, M., Haastert, B., & Hube, F. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800773 · Cited by 131
Sérino, M., Menghini, R., Fiorentino, L., Amoruso, R., Mauriello, A., Lauro, D., Sbraccia, P., Hribal, M. L., Lauro, R., & Federici, M. (2007) · Diabetes · doi:10.2337/db07-0360 · Cited by 115
Hube, Birgel, Lee, & Hauner (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00520.x · Cited by 112
Fat uses a TOLL-road to connect inflammation and diabetes
Kim, J. K. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.11.008 · Cited by 109
Lo, J., Bernstein, L. E., Hron, B. M., Torriani, M., Jackson, M. B., Ahima, R. S., & Grinspoon, S. K. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00089.2007 · Cited by 108
Xu, H., Hirosumi, J., Uysal, K. T., Güler, A. D., & Hotamışlıgil, G. S. (2002) · Endocrinology · doi:10.1210/endo.143.4.8715 · Cited by 105
Pamir, N., McMillen, T. S., Kaiyala, K. J., Schwartz, M. W., & LeBoeuf, R. C. (2009) · Endocrinology · doi:10.1210/en.2009-0137 · Cited by 100
Monroy, A., Kamath, S., Chávez, A. O., Centonze, V. E., Veerasamy, M., Barrentine, A., Wewer, J. J., Coletta, D. K., Jenkinson, C. P., Jhingan, R. M., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1451-3 · Cited by 99
Getting away from glucose: fanning the flames of obesity-induced inflammation
Shoelson, S. E., & Goldfine, A. B. (2009) · Nature Medicine · doi:10.1038/nm0409-373 · Cited by 98
Fernández‐Veledo, S., Vila‐Bedmar, R., Nieto-Vázquez, I., & Lorenzo, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0558 · Cited by 97
Liang, H., Yin, B., Zhang, H., Zhang, S., Zeng, Q., Wang, J., Jiang, X., Li, Y., Wang, C., & Li, Z. (2008) · Endocrinology · doi:10.1210/en.2007-0978 · Cited by 94
Löfgren, P., van Harmelen, V., Reynisdottir, S., Näslund, E. B., Rydén, M., Rössner, S. M., & Arner, P. (2000) · Diabetes · doi:10.2337/diabetes.49.5.688 · Cited by 91
Maury, E., Noël, L., Detry, R. J., & Brichard, S. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2196 · Cited by 83
Deficiency of TNFα Converting Enzyme (TACE/ADAM17) Causes a Lean, Hypermetabolic Phenotype in Mice
Gelling, R. W., Yan, W., Al‐Noori, S., Pardini, A. W., Morton, G. J., Ogimoto, K., Schwartz, M. W., & Dempsey, P. J. (2008) · Endocrinology · doi:10.1210/en.2008-0775 · Cited by 80
Monocyte Chemoattractant Protein‐1 in Obesity and Type 2 Diabetes. Insulin Sensitivity Study
Chacón, M. R., Fernández‐Real, J. M., Richart, C., Megía, A., Gómez, J. M., Miranda, M., Caubet, E., Pastor, R., Noguera, C. M., Vilarrasa, N., et al. (2007) · Obesity · doi:10.1038/oby.2007.578 · Cited by 52
Pandey, M., Tuncman, G., Hotamışlıgil, G. S., & Samad, F. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63888-6 · Cited by 44
Inflammatory cytokines in insulin-treated patients with type 2 diabetes
Mavridis, G., Souliou, E., Diza, E., Symeonidis, G., Pastore, F., Vassiliou, A. M., & Karamitsos, D. T. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.013 · Cited by 40
Sarzi-Puttini, P., Atzeni, F., Schölmerich, J., Cutolo, M., & Straub, R. H. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.040816 · Cited by 39
Is NF-κB a culprit in type 2 diabetes?
Chen, F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.075 · Cited by 37
Interaction of Tumor Necrosis Factor-α- and Thiazolidinedione-Regulated Pathways in Obesity
Wellen, K. E., Uysal, K. T., Wiesbrock, S. M., Yang, Q., Chen, H., & Hotamışlıgil, G. S. (2004) · Endocrinology · doi:10.1210/en.2003-1580 · Cited by 33
Autoamplification of Tumor Necrosis Factor-α
Neels, J. G., Pandey, M., Hotamışlıgil, G. S., & Samad, F. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050699 · Cited by 30
Influence of membrane‐bound tumor necrosis factor (TNF)‐α on obesity and glucose metabolism
Vörös, G., Maquoi, E., Collen, D., & LIJNEN, H. R. (2004) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7933.2004.00612.x · Cited by 23
Fernández‐Real, J. M., Botas-Cervero, P., Lainez, B., Ricart, W., & Delgado, E. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.07.011 · Cited by 10
Cited by
Aggarwal, B. B., Gupta, S. C., & Kim, J. H. (2012) · Blood · doi:10.1182/blood-2011-04-325225 · Cited by 877
Akash, M. S. H., Rehman, K., & Liaqat, A. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26174 · Cited by 690
Anti-inflammatory activity of natural dietary flavonoids
Pan, M.-H., Lai, C.-S., & Ho, C.-T. (2010) · Food & Function · doi:10.1039/c0fo00103a · Cited by 605
Poroyko, V. A., Carreras, A., Khalyfa, A., Khalyfa, A. A., Leone, V., Peris, E., Almendros, I., Gileles-Hillel, A., Qiao, Z., Hubert, N., et al. (2016) · Scientific Reports · doi:10.1038/srep35405 · Cited by 480
Insulin resistance and cardiovascular disease
Kosmas, C. E., Bousvarou, M. D., Kostara, C. E., Papakonstantinou, E. J., Salamou, E., & Guzman, E. (2023) · Journal of International Medical Research · doi:10.1177/03000605231164548 · Cited by 385
Metadata
- Authors
- Tzanavari, T., Giannogonas, P., & Karalis, K. P.
- Venue
- Current Directions in Autoimmunity
- Publisher
- KARGER
- Published
- 2010
- Volume
- 11
- Pages
- 145-156
- ISSN
- 1422-2132 (ISSN-L)
- OpenAlex
- W1514693175
- Cited by
- 322
- References
- 77
- FWCI
- 56.56
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.